Videos

Rybrevant Plus Chemotherapy May Improve PFS for Relapsed EGFR Lung Cancer

October 12th 2024, 6:00pm

Video

The drug combined with chemotherapy demonstrated a 60% increase in progression-free survival, suggesting signs of an FDA approval.

High vs Low Dose of Vitamin D May Not Impact Treating mCRC

October 7th 2024, 9:00pm

Video

For patients with metastatic colorectal cancer, adding a higher dose proves just as effective as the standard dose of vitamin D3, despite one exception.

Challenges to Consider While Receiving Fotivda for Kidney Cancer

September 21st 2024, 2:00pm

Video

At the 2024 ESMO Congress, CURE® spoke with an expert about Fotivda and certain challenges patients may experience, such as side effects.

The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration

September 20th 2024, 12:59pm

Video

The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in care decisions.

Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors

September 20th 2024, 12:57pm

Video

The discussion will explore the impact of fixed-duration treatments on quality of life, benefits and challenges compared with continuous therapy, financial considerations, and lifestyle goals during and after treatment.

Therapies for Some With Prostate Cancer Focuses on Reducing Side Effects

September 16th 2024, 3:00pm

Video

At the 2024 ESMO Congress, an expert explained how Nubeqa may reduce fatigue-related side effects in metastatic hormone-sensitive prostate cancer.

Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs

September 13th 2024, 2:54pm

Video

The discussion will cover fixed-duration treatments vs continuous therapy for CLL and provide a brief overview of venetoclax-based regimens approved for 12 cycles with obinutuzumab and 24 cycles with rituximab.

CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making

September 13th 2024, 2:52pm

Video

The discussion will cover experiences with CLL treatment, focusing on key factors in treatment decisions, how care teams educate patients about options, strategies for discussing adverse events, and communicating adverse effects to the care team.

Patient Characteristics Guide Decision Making for JAK Inhibitors in Myelofibrosis

September 9th 2024, 3:00pm

Video

Spleen size, blood counts and symptom burden are some of the factors cancer teams take into account when selecting which of the four JAK inhibitors to treat patient with myelofibrosis.

LL Treatment Roadmap: Navigating First-Line Options With Your Doctor

September 6th 2024, 2:50pm

Video

The discussion will cover the current CLL treatment landscape, including first-line and later-line options; the medical experts will review first-line treatments, approach to treatment selection, factors influencing recommendations, and strategies for shared decision-making with patients.